EUVIMEDEUVIMED entdecken
Crossref

WHO updates rules calling for methadone or buprenorphine for OUD

Alison Knopf

Alcoholism & Drug Abuse Weekly · 13.04.2026 · 38 (15) · 8-8

DOI: 10.1002/adaw.34876 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alcoholism & Drug Abuse Weekly, online erschienen am 10.04.2026. Verfasst von Alison Knopf.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The World Health Organization (WHO) has called on treatment providers worldwide to rely on two treatments for opioid use disorder (OUD): methadone and buprenorphine. Worldwide, OUD is a major contributor to morbidity and mortality. According to WHO, of 600,000 deaths attributed to drug use, about 450,000 are due to opioid use.

Zitieren

APA

Knopf, A. (2026). WHO updates rules calling for methadone or buprenorphine for OUD. Alcoholism & Drug Abuse Weekly, 38(15), 8-8. https://doi.org/10.1002/adaw.34876

Vancouver

Knopf A. WHO updates rules calling for methadone or buprenorphine for OUD. Alcoholism & Drug Abuse Weekly. 2026;38(15):8-8. doi:10.1002/adaw.34876

BibTeX
@article{Knopf2026,
  author = {Knopf, Alison},
  title = {WHO updates rules calling for methadone or buprenorphine for OUD},
  journal = {Alcoholism & Drug Abuse Weekly},
  year = {2026},
  volume = {38},
  number = {15},
  pages = {8--8},
  doi = {10.1002/adaw.34876}
}
Kostenlos starten →